AI assistant
PMV Pharmaceuticals, Inc. — Director's Dealing 2024
Oct 3, 2024
34350_dirs_2024-10-03_56e7b1df-35f1-4bc9-8a0e-f07c578f056b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2024-08-13
Reporting Person: Mack David Henry (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-13 | Employee Stock Option (right to buy) | $28.33 | D | 134584 | Disposed | 2031-05-11 | Common Stock (134584) | Direct |
| 2024-08-13 | Employee Stock Option (right to buy) | $16.29 | D | 249600 | Disposed | 2032-02-10 | Common Stock (249600) | Direct |
| 2024-08-13 | Employee Stock Option (right to buy) | $1.48 | A | 384184 | Acquired | 2034-08-13 | Common Stock (384184) | Direct |
| 2024-08-13 | Employee Stock Option (right to buy) | $5.70 | D | 330000 | Disposed | 2033-05-12 | Common Stock (330000) | Direct |
| 2024-08-13 | Employee Stock Option (right to buy) | $1.48 | A | 330000 | Acquired | 2034-08-13 | Common Stock (330000) | Direct |
Footnotes
F1: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.
F2: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share.
F3: Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.
F4: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share.
F5: One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
F6: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.
F7: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share.
F8: One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.